Lung Cancer

About the Cancer

Patient Appointments

Please call (202) 444-2223
Monday – Friday,
8:30 am – 5:00 pm

Currently Available Clinical Trials from Georgetown Lombardi

More clinical trials are available on NIH’s national clinical trial database and Lombardi’s clinical trials resources.

You will be redirected to our clinical partner, MedStar Georgetown University Hospital.

Georgetown Lombardi Comprehensive Cancer Center is committed to providing you with the most current information and resources available on lung cancers. Learn more about lung cancer (new window) and lung cancer treatments (new window) at Medstar Georgetown University Hospital.

Additionally, current information about lung cancers (Non-Small Cell, Small Cell), incidence and survival statistics, treatment options, causes and prevention, coping strategies, clinical trials, and research is available online from the National Cancer Institute (new window) at the National Institutes of Health. (new window) See also Mesothelioma (new window).

What We Offer

  • Interdisciplinary Lung Cancer Clinic (ILC) The evaluation and management of lung cancer is complex, requiring a comprehensive approach with the involvement of experts from multiple specialties. It is exactly this multi-disciplinary approach that the Georgetown Lombardi Comprehensive Cancer Center provides through its Interdisciplinary Lung Cancer Clinic (ILC).

Cancer Research

Lung cancer remains the leading cause of cancer deaths, accounting for nearly a third of all deaths due to cancer. It is imperative that we explore newer and better treatments for patients with lung cancer. Our robust research program within the Interdisciplinary Lung Cancer Clinic (ILC) offers a wide range of clinical trials for patients with lung cancer, exploring novel therapeutics. Additionally, we are also performing studies to understand the biology of lung cancer, with an aim to develop strategies for early diagnosis and tailor therapies to the needs of individual patients.